Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Catherine Angell Sohn founded Sohn Health Strategies LLC. Currently, Dr. Sohn is Non-Executive Chairman at BioEclipse Therapeutics, Inc. Dr. Sohn is also Professor at the University of the Sciences in Philadelphia and on the board of 10 other companies.

In the past Dr. Sohn held the position of President for Sohn Health Strategies LLC, Senior Vice President at GlaxoSmithKline Plc Senior Vice President-Business Development for GlaxoSmithKline Consumer Healthcare LP and Senior Vice President-Worldwide Business at GlaxoSmithKline LLC (both are subsidiaries of GlaxoSmithKline Plc), VP-Worldwide Strategic Product Development at Smithkline Beecham Pharmaceuticals Ltd., Chairman for Eclipse Therapeutics, Inc., Adjunct Professor at The University of California, San Francisco and Professor at Philadelphia College of Pharmacy.

Dr. Sohn received a doctorate from The University of California, San Francisco.

Current positions of Catherine Angell Sohn 
NameTitle Since
Jazz Pharmaceuticals plc
Independent Director 2012
Rubius Therapeutics, Inc.
(Biotechnology & Medical Research)
Independent Director 2018
Landec Corporation
(Food Processing)
Independent Director 2012
Axcella Health Inc.
(Biotechnology & Medical Research)
Independent Director 2019
BioEclipse Therapeutics, Inc. Non-Executive Chairman 2016
Jazz Pharmaceuticals, Inc. Director 2012
World Affairs Council of Philadelphia Director -
Eversana Life Science Services LLC Director -
Dohmen Co. Director 2012
Ariel Pharmaceuticals, Inc. Director -
Maze Therapeutics, Inc. Director 2021
University of the Sciences in Philadelphia Professor 2013

Holdings of Catherine Angell Sohn 
Jazz Pharmaceuticals plc (JAZZ)
11,5620.019%1,522,831 USD
Landec Corporation (LNDC)
(Food Processing)
38,7070.13%419,197 USD
Rubius Therapeutics, Inc. (RUBY)
(Biotechnology & Medical Research)
2,5000.0028%54,300 USD
Axcella Health Inc. (AXLA)
(Biotechnology & Medical Research)
1,0000.0026%3,650 USD

Catherine Angell Sohn: Personal Network 
Most Read News 
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
09/08MICHAEL O'LEARY : Exclusive-Ryanair ready to wait years for Boeing to cut prices, says O'Leary
More news

© 2021 People and Ownership :   
Catherine Angell Sohn : Connections